Φορτώνει......
Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer
BACKGROUND: New biomarkers for early detection of cancer must pass through several phases of development. Early phases provide information on diagnostic properties but not on population benefits and harms. Prostate cancer antigen 3 (PCA3) is a promising prostate cancer biomarker still in early devel...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4383671/ https://ncbi.nlm.nih.gov/pubmed/25613117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-14-1224 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|